<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2021-1S-45-49</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-1648</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ И МЕТОДИКИ</subject></subj-group></article-categories><title-group><article-title>Art therapy possibilities in the complex treatment of patients with multiple sclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>Возможности арт-терапии в комплексном лечении пациентов с рассеянным склерозом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гусева</surname><given-names>М. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Guseva</surname><given-names>M. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра неврологии, нейрохирургии и медицинской генетики</p><p>117997, Москва, ул. Островитянова, 1107113, Москва, ул. Рыбинская 3-я, 18, стр. 19</p></bio><bio xml:lang="en"><p>Department of Neurology, Neurosurgery, and Medical Genetics</p><p>1, Ostrovityanov St., Moscow 11799718, Rybinskaya 3-ya St., Build. 19, Moscow 107113</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матвиевская</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Matvievskaya</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>125480, Москва, ул. Планерная, 7, корп. 1</p></bio><bio xml:lang="en"><p>7, Planernaya St., Build. 1, Moscow 125480</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бойко</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Boyko</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алексей Николаевич Бойко</p><p>Кафедра неврологии, нейрохирургии и медицинской генетики</p><p>отдел нейроиммунологии</p><p>117997, Москва, ул. Островитянова, 1117997, Москва, улица Островитянова, 1, стр. 10</p></bio><bio xml:lang="en"><p>Aleksey Nikolaevich Boyko</p><p>Department of Neurology, Neurosurgery, and Medical Genetics</p><p>Department of Neuroimmunology</p><p>1, Ostrovityanov St., Moscow 1179971, Ostrovityanov St., Build 10, Moscow 117997</p></bio><email xlink:type="simple">boykoan13@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; ОЧУ ДПО «Институт междисциплинарной медицины»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Institute of Interdisciplinary Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Межрегиональная общественная организация инвалидов «Московское общество рассеянного склероза»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Interregional Public Organization of Disabled People «Moscow Society of Multiple Sclerosis»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; ФГБУ «Федеральный центр мозга и нейротехнологий» ФМБА России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Federal Center of Brain and Neurotechnologies, FMBA of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>14</day><month>09</month><year>2021</year></pub-date><volume>13</volume><issue>1S</issue><issue-title>Спецвыпуск: рассеянный склероз</issue-title><fpage>45</fpage><lpage>49</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Guseva M.E., Matvievskaya O.V., Boyko A.N., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Гусева М.Е., Матвиевская О.В., Бойко А.Н.</copyright-holder><copyright-holder xml:lang="en">Guseva M.E., Matvievskaya O.V., Boyko A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/1648">https://nnp.ima-press.net/nnp/article/view/1648</self-uri><abstract><sec><title>Objective</title><p>Objective: to study the effectiveness of art therapy methods in the complex treatment of neuropsychological disorders and quality of life improvement in patients with relapsing-remitting and secondary-progressive multiple sclerosis (MS).</p></sec><sec><title>Patients and methods</title><p>Patients and methods. A group of 42 patients (5 men and 37 women, mean age 32.9 years, mean EDSS severity 3.8 points) with MS underwent outpatient continuous active art therapy cycle. The mean group training cycle duration was six months. The comparison group included 15 age- and sex-adjusted individuals without neurological disorders. Tests on various drawing topics were carried out before and after a three-month therapy course. We used Hospital Anxiety and Depression Scale (HADS) to assess the severity of anxiety and depression and the SF-36 scale to evaluate the quality of life (QoL).</p></sec><sec><title>Results and discussion</title><p>Results and discussion. Before the art therapy start, light blue, yellow, pink, blue, and green colors prevailed in the drawings. There was no predominance of any color depending on MS severity or course. The green color predominated in this test in the control group, and the light blue color was significantly less represented. The art therapy course did not lead to a significant change in the severity of MS according to the </p><p>Expanded Disability Status Scale (EDSS). After the art therapy course, the color scheme of the drawings was mainly represented by red, light blue, green, yellow, and blue colors. In addition, a red-orange color appeared in the drawings, which was completely absent before the course. Positive trends were noted according to HADS: a decrease in anxiety by 23% and depression by 19%. The physical component of QoL assessed by the SF-36 scale did not change substantially, but the psychological component significantly improved by 11%.</p></sec><sec><title>Conclusion</title><p>Conclusion. The predominance of light blue color observed in MS is associated with damage to the nervous and musculoskeletal systems, and blue color – with psychological problems and depression. However, after a course of art therapy for MS, red, red-orange, yellow, and green colors representation increased significantly, which indicates an increase in positive attitude, a decrease in the level of depression, and an improvement in QoL.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Цель исследования – изучение эффективности методов арт-терапии в комплексном лечении нейропсихологических нарушений и динамики качества жизни у пациентов с ремиттирующим и вторично-прогрессирующим рассеянным склерозом (РС).</p><sec><title>Пациенты и методы</title><p>Пациенты и методы. В группе из 42 пациентов (5 мужчин и 37 женщин, средний возраст – 32,9 года, средняя тяжесть по шкале EDSS – 3,8 балла) c РС проводили цикл амбулаторной непрерывной активной арт-терапии. Средняя продолжительность цикла занятий в группе составила 6 мес. Группа сравнения состояла из 15 лиц того же возраста и с таким же распределением по полу без неврологической патологии. Тесты по различным темам рисунка проводились до и после трехмесячного курса терапии. Оценивали выраженность тревоги и депрессии по Госпитальной шкале тревоги и депрессии (Hospital Anxiety and Depression Scale, HADS), а также качество жизни (КЖ) по шкале SF-36.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. До начала арт-терапии на рисунках преобладали голубой, желтый, розовый, синий и зеленый цвета. Не получено преобладания какого-либо цвета в зависимости от тяжести или типа течения РС. В контрольной группе в этом тесте преобладал зеленый, статистически значимо в меньшей степени был представлен голубой цвет. Курс арт-терапии не привел к значимому изменению тяжести РС по Расширенной шкале оценки степени инвалидизации (Expanded Disability Status Scale, EDSS). После курса арт-терапии в цветовой гамме рисунков преобладали красный, голубой, зеленый, желтый и синий цвета, появился на рисунках красно-оранжевый цвет, полностью отсутствовавший до курса. По HADS отмечены позитивные тенденции в виде уменьшения показателя тревоги на 23% и депрессии на 19%. Физический компонент КЖ по шкале SF-36 практически не изменился, но психологический компонент значимо улучшился – на 11%.</p></sec><sec><title>Заключение</title><p>Заключение. Преобладание голубого цвета, наблюдаемое при РС, связывают с повреждением нервной и опорно-двигательной систем, а синего – с наличием психологических проблем и депрессией. После курса арт-терапии при РС значительно увеличилась тенденция доминирования красного, красно-оранжевого, желтого и зеленого цветов, что свидетельствует о повышении позитивного настроя, снижении уровня депрессии, улучшении КЖ.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рассеянный склероз</kwd><kwd>арт-терапия</kwd><kwd>цветотерапия</kwd><kwd>депрессия</kwd><kwd>качество жизни</kwd></kwd-group><kwd-group xml:lang="en"><kwd>multiple sclerosis</kwd><kwd>art therapy</kwd><kwd>color therapy</kwd><kwd>depression</kwd><kwd>quality of life</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бойко АН, Гусева МЕ, Сиверцева СА. Немедикаментозные методы лечения и образ жизни при рассеянном склерозе. Москва: ГЭОТАР-Медиа; 2015. 239 с.</mixed-citation><mixed-citation xml:lang="en">Boyko AN, Guseva ME, Sivertseva SA. Nemedikamentoznyye metody lecheniya i obraz zhizni pri rasseyannom skleroze [Non-drug treatment methods and lifestyle in multiple sclerosis]. Moscow: GEOTAR-Media; 2015. 239 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Newland P, Miller R, Bettencourt BA, Hendricks-Ferguson V. Pilot Study of Videos to Deliver Mindfulness-Based Art Therapy for Adults With Multiple Sclerosis. J Neurosci Nurs. 2020;52(6):E19-E23. doi: 10.1097/JNN.0000000000000547</mixed-citation><mixed-citation xml:lang="en">Newland P, Miller R, Bettencourt BA, Hendricks-Ferguson V. Pilot Study of Videos to Deliver Mindfulness-Based Art Therapy for Adults With Multiple Sclerosis. J Neurosci Nurs. 2020;52(6):E19-E23. doi: 10.1097/JNN.0000000000000547</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Van Geel F, van Asch P, Veldkamp R, Feys P. Effects of a 10-week multimodal dance and art intervention program leading to a public performance in persons with multiple sclerosisA controlled pilot-trial. Mult Scler Relat Disord. 2020;44:102256. doi: 10.1016/j.msard.2020.102256</mixed-citation><mixed-citation xml:lang="en">Van Geel F, van Asch P, Veldkamp R, Feys P. Effects of a 10-week multimodal dance and art intervention program leading to a public performance in persons with multiple sclerosisA controlled pilot-trial. Mult Scler Relat Disord. 2020;44:102256. doi: 10.1016/j.msard.2020.102256</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Newland P, Bettencourt BA. Effectiveness of mindfulness-based art therapy for symptoms of anxiety, depression, and fatigue: A systematic review and meta-analysis. Complement Ther Clin Pract. 2020;41:101246. doi: 10.1016/j.ctcp.2020.101246</mixed-citation><mixed-citation xml:lang="en">Newland P, Bettencourt BA. Effectiveness of mindfulness-based art therapy for symptoms of anxiety, depression, and fatigue: A systematic review and meta-analysis. Complement Ther Clin Pract. 2020;41:101246. doi: 10.1016/j.ctcp.2020.101246</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-73. doi: 10.1016/S1474-4422(17)30470-2</mixed-citation><mixed-citation xml:lang="en">Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-73. doi: 10.1016/S1474-4422(17)30470-2</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Patti F, Russo P, Pappalardo A, et al. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study. J Neurol Sci. 2007;252(2):121-9. doi: 10.1016/j.jns.2006.10.017</mixed-citation><mixed-citation xml:lang="en">Patti F, Russo P, Pappalardo A, et al. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study. J Neurol Sci. 2007;252(2):121-9. doi: 10.1016/j.jns.2006.10.017</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Бойко ОВ, Татаринова МЮ, Попова ЕВ и др. Улучшение показателей качества жизни больных рассеянным склерозом за 15-летний период. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(8-2):23-8.</mixed-citation><mixed-citation xml:lang="en">Boyko OV, Tatarinova MYu, Popova EV, et al. The improvement of quality of life of patients with multiple sclerosis over 15-year period. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018;118(8-2):23-8. doi: 10.17116/jnevro201811808223 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Гусева МЕ. Арт-терапия при рассеянном склерозе. В кн.: Гусев ЕИ, Бойко АН. Рассеянный склероз. Научно-практическое руководство. Москва: РООИ «Здоровье человека»; 2020. Т. 2. С. 461-76.</mixed-citation><mixed-citation xml:lang="en">Guseva ME. Art therapy for multiple sclerosis. In: Gusev EI, Boyko AN. Rasseyannyy skleroz. Nauchno-prakticheskoye rukovodstvo [Multiple sclerosis. Scientific and practical guide]. Moscow: ROOI «Human Health»; 2020. Vol. 2. P. 461-76 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jang SH, Lee JH, Lee HJ, Lee SY. Effects of Mindfulness-Based Art Therapy on Psychological Symptoms in Patients with Coronary Artery Disease. J Korean Med Sci. 2018;33(12):e88. doi: 10.3346/jkms.2018.33.e88</mixed-citation><mixed-citation xml:lang="en">Jang SH, Lee JH, Lee HJ, Lee SY. Effects of Mindfulness-Based Art Therapy on Psychological Symptoms in Patients with Coronary Artery Disease. J Korean Med Sci. 2018;33(12):e88. doi: 10.3346/jkms.2018.33.e88</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Лебедева ЛД, Никонорова ЮВ, Тараканова НА. Энциклопедия признаков и интерпретаций в проективном рисовании и арт-терапии. Санкт-Петербург: Речь; 2010. 332 с.</mixed-citation><mixed-citation xml:lang="en">Lebedeva LD, Nikonorova YuV, Tarakanova NA. Entsiklopediya priznakov i interpretatsiy v proyektivnom risovanii i art-terapii [Encyclopedia of signs and interpretations in projective drawing and art therapy]. St. Petersburg: Rech, 2010. 332 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Abbott RA, Whear R, Rodgers LR, et al. Effectiveness of mindfulness-based stress reduction and mindfulness based cognitive therapy in vascular disease: a systematic review and meta-analysis of randomised controlled trials. J Psychosom Res. 2014;76(5):341-51. doi: 10.1016/j.jpsychores.2014.02.012</mixed-citation><mixed-citation xml:lang="en">Abbott RA, Whear R, Rodgers LR, et al. Effectiveness of mindfulness-based stress reduction and mindfulness based cognitive therapy in vascular disease: a systematic review and meta-analysis of randomised controlled trials. J Psychosom Res. 2014;76(5):341-51. doi: 10.1016/j.jpsychores.2014.02.012</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Nyklicek I, Dijksman SC, Lenders PJ, et al. A brief mindfulness based intervention for increase in emotional well-being and quality of life in percutaneous coronary intervention (PCI) patients: the MindfulHeart randomized controlled trial. J Behav Med. 2014;37(1):135-44. doi: 10.1007/s10865-012-9475-4</mixed-citation><mixed-citation xml:lang="en">Nyklicek I, Dijksman SC, Lenders PJ, et al. A brief mindfulness based intervention for increase in emotional well-being and quality of life in percutaneous coronary intervention (PCI) patients: the MindfulHeart randomized controlled trial. J Behav Med. 2014;37(1):135-44. doi: 10.1007/s10865-012-9475-4</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Малыгин ВЛ, Бойко АН, Коновалова ОЕ и др. Влияние психопатологических факторов и особенностей личности на результаты исследования качества жизни больных рассеянным склерозом. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(2-2):42-8.</mixed-citation><mixed-citation xml:lang="en">Malygin VL, Boyko AN, Konovalova OE, et al. Influence of psychopathological factors and personality traits on the results of the study of quality of life in patients with multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2019;119(2-2):42-8. doi: 10.17116/jnevro20191192242 (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
